<DOC>
<DOCNO>EP-0656358</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Process for the preparation of imidazopyridinderivatives.
</INVENTION-TITLE>
<CLASSIFICATIONS>B01J3104	B01J3104	C07B6100	C07B6100	C07D47100	C07D47104	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>B01J	B01J	C07B	C07B	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>B01J31	B01J31	C07B61	C07B61	C07D471	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
A process for the preparation of imidazopyridine derivatives of the general formula 
<
IMAGE
>
 entails a 2-amino-3-nitropyridine being hydrogenated in the presence of a hydrogenation catalyst, and the hydrogenation product being condensed with a carboxylic acid, which is simultaneously present in the reaction mixture, to give the final product. The imidazopyridine derivatives are intermediates for the preparation of angiotensin II antagonists.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
LONZA AG
</APPLICANT-NAME>
<APPLICANT-NAME>
LONZA AG
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
EYER MARTIN DR
</INVENTOR-NAME>
<INVENTOR-NAME>
KUO DAVID L DR
</INVENTOR-NAME>
<INVENTOR-NAME>
RODUIT JEAN-PAUL DR
</INVENTOR-NAME>
<INVENTOR-NAME>
WELLIG ALAIN
</INVENTOR-NAME>
<INVENTOR-NAME>
EYER, MARTIN, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
KUO, DAVID L. DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
RODUIT, JEAN-PAUL, DR.
</INVENTOR-NAME>
<INVENTOR-NAME>
WELLIG, ALAIN
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
